Print
Email
Print Edition StoriesMonday, December 7, 2009
5AM Ventures closes $200M third fund
By Mass High Tech staff
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
Breaking down the MIT $100K
Venture capital firm 5AM Venture Management LLC has closed its third fund at $200 million, the company announced today.
The firm, which has offices in both Waltham and Menlo Park, Calif., raised the fund from endowments, foundations, family offices, funds of funds and pension funds. It had listed initially raising $159 million in a July regulatory filing.
Founded in 2002 and focused on early stage life sciences companies, 5AM Ventures lists its managing partners as John Diekman, Scott Rocklage and Andy Schwab. Among its 27 investments, it has backed Lexington-based biotech Pulmatrix Inc.; Cambridge-based Semprus BioSciences Corp., an antibacterial coatings biomedical company; and California firms Relypsa Inc., Pearl Therapeutics and Ambrx Inc.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
